MP0712-CP101 A phase 1/2a study to assess safety, tolerability, and efficacy of [212Pb]Pb-DOTAM-MAM279 in patients with small cell lung cancer and other DLL3 expressing solid tumors

  • Phase I
  • Trial Category: Lung

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha, NE location

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*